Skip to main content

Table 1 The global incidence, prevalence, mortality, and dalys for six gynecological system diseases from 1990 to 2021

From: The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021

Year

PCOS

Endometriosis

Uterine fibroids

Cervical cancer

Ovarian cancer

Uterine cancer

1990

      

Incidence (× 105, 95% UI)

14.76(10.58–20.45)

33.30(23.09–45.07)

60.10(43.90-80.11)

4.10(3.83–4.39)

1.59(14.57-17,41)

1.91(1.75–2.012)

Prevalence (× 105, 95% UI)

366.51(262.28-506.04)

198.70(135.86–276.90)

656.95(500.22-855.58)

18.26(17.27–19.29)

6.29(5.72–6.93)

13.33(12.26–13.99)

Mortality (95% UI)

-

24.83(13.90-48.88)

1125.85(765.03-1456.02)

211483.79(195724.27-229841.01)

100584.11(92970.81-109087.03)

54848.89(48803.56-59116.13)

DALYs (× 105, 95% UI)

3.24(1.44–6.8)

18.29(10.33–2.86)

0.81(0.57–1.12)

74.16(68.41–80.71)

29.09(26.62–31.99)

15.01(12.98–16.38)

ASIR (1/100,000, 95% UI)

49.45(35.57–68.45)

119.65(83.51-160.46)

234.36(171.06-309.92)

18.11(16.94–19.40)

7.22(6.65–7.87)

8.87(8.12–9.35)

ASPR (1/100,000, 95% UI)

1372.77(984.64-1891.60)

757.10(515.25-1046.13)

2799.88(2133.46-3650.54)

78.15(73.89–82.51)

27.62(25.26–30.26)

61.17(56.35–64.14)

ASMR (1/100,000, 95% UI)

-

0.00(0.00–0.00)

0.05(0.04–0.07)

9.68(8.97–10.51)

4.73(4.38–5.12)

2.60(2.32–2.80)

ASDR (1/100,000, 95% UI)

12.08(5.38–25.21)

69.60(39.69-109.37)

3.48(2.46–4.77)

330.11(304.67–359.10)

132.48(121.34-145.63)

69.17(59.85–75.30)

2021

      

Incidence (× 105, 95% UI)

23.02(16.56–31.67)

34.47(24.36–46.12)

101.00(73.50-132.86)

6.67(6.13–7.26)

2.99(2.71–3.25)

4.74(4.30–5.14)

Prevalence (× 105, 95% UI)

694.73(495.31-957.24)

222.75(155.17-304.14)

1195.45(912.28-1549.44)

33.85(31.08–36.97)

12.22(11.02–13.32)

34.52(31.65–37.25)

Mortality (95% UI)

-

54.17(21.51-121.92)

2077.75(1225.41-2574.28)

296667.24(272058.62-321905.72)

185608.68(167961.98-201012.67)

97672.08(86515.79-108061.54)

DALYs (× 105, 95% UI)

6.08(2.73–12.69)

20.49(11.95–31.34)

1.43(1.02–1.93)

99.12(90.53-107.98)

51.63(46.92–56.08)

25.63(22.91–28.46)

ASIR (1/100,000, 95% UI)

63.26(45.41–87.28)

88.52(62.53-119.55)

250.93(183.44-330.94)

15.32(14.08–16.68)

6.71(6.07–7.28)

10.36(9.42–11.24)

ASPR (1/100,000, 95% UI)

1757.83(1253.36-2421.26)

556.98(388.85-764.05)

2841.07(2164.43-3682.27)

79.30(72.81–86.58)

28.08(25.26–30.64)

75.73(69.37–81.78)

ASMR (1/100,000, 95% UI)

-

0.00(0.00–0.00)

0.05(0.03–0.06)

6.62(6.07–7.18)

4.06(3.67–4.40)

2.11(1.87–2.34)

ASDR (1/100,000, 95% UI)

15.40(6.91–32.13)

51.27(29.87–78.43)

3.39(2.43–4.59)

226.28(206.51-246.86)

115.15(104.58-125.21)

56.15(50.07–62.37)

1990–2021

      

ASIR (EAPC, 95% CI)

0.77(0.75–0.79)

-1.00(-1.05–0.95)

0.24(0.23–0.25)

-0.54(-0.64–0.44)

-0.38(-0.43–0.32)

0.54(0.50–0.58)

ASPR (EAPC, 95% CI)

0.74(0.70–0.77)

-1.02(-1.07–0.97)

0.04(0.03–0.06)

0.12(0.03–0.21)

-0.07(-0.13-0.00)

0.77(0.72–0.82)

ASMR (EAPC, 95% CI)

-

1.27(1.03–1.51)

0.06(-0.07-0.20)

-1.27(-1.36–1.18)

-0.62(-0.68–0.57)

-0.78(-0.85–0.70)

ASDR (EAPC, 95% CI)

0.72(0.68–0.76)

-1.01(-1.06–0.96)

0.05(-0.01-0.11)

-1.27(-1.36–1.17)

-0.59(-0.64–0.54)

-0.78(-0.85–0.71)